BCV
WST icon

Banque Cantonale Vaudoise’s West Pharmaceutical WST Stock Holding History

Banque Cantonale Vaudoise’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Buy
4,643
+4,290
+1,215% +$1.31M ﹤0.01% 380
2026
Q1 		$88K Buy
+353
New +$87.8K ﹤0.01% 731
2025
Q3 		– Sell
-6,501
Closed -$1.42M – 867
2025
Q2 		$1.42M Buy
6,501
+835
+15% +$179K 0.06% 302
2025
Q1 		$1.27M Buy
+5,666
New +$1.56M 0.06% 309
2024
Q3 		$813K Sell
2,707
-5,066
-65% -$1.55M 0.03% 343
2024
Q2 		$2.56M Buy
7,773
+1,691
+28% +$598K 0.1% 195
2024
Q1 		$2.41M Sell
6,082
-26
-0.4% -$9.62K 0.09% 219
2023
Q4 		$2.15M Buy
6,108
+2,574
+73% +$911K 0.09% 220
2023
Q3 		$1.33M Sell
3,534
-667
-16% -$258K 0.07% 253
2023
Q2 		$1.61M Buy
4,201
+2,301
+121% +$822K 0.08% 230
2023
Q1 		$659K Hold
1,900
– – 0.03% 393
2022
Q4 		$447K Hold
1,900
– – 0.02% 473
2022
Q3 		$467K Hold
1,900
– – 0.03% 494
2022
Q2 		$575K Sell
1,900
-600
-24% -$195K 0.03% 459
2022
Q1 		$1.03M Hold
2,500
– – 0.04% 382
2021
Q4 		$1.17M Sell
2,500
-3,681
-60% -$1.58M 0.05% 379
2021
Q3 		$2.62M Buy
6,181
+1,738
+39% +$733K 0.11% 177
2021
Q2 		$1.59M Buy
4,443
+1,643
+59% +$543K 0.07% 292
2021
Q1 		$789K Sell
2,800
-1,500
-35% -$429K 0.04% 429
2020
Q4 		$1.22M Hold
4,300
– – 0.07% 259
2020
Q3 		$1.18M Sell
4,300
-200
-4% -$52.9K 0.08% 230
2020
Q2 		$1.02M Sell
4,500
-6,500
-59% -$1.28M 0.07% 267
2020
Q1 		$1.67M Buy
11,000
+3,200
+41% +$493K 0.14% 151
2019
Q4 		$1.17M Buy
+7,800
New +$1.14M 0.08% 263

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Banque Cantonale Vaudoise's WST Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its West Pharmaceutical (WST) stake by 1,215% in Q2 2026, buying an estimated $1.31M and bringing the position to 4,643 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #380.

Banque Cantonale Vaudoise first reported a position in WST in Q4 2019 and has held it in 24 quarters since. The position peaked at $2.62M in Q3 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Banque Cantonale Vaudoise held 4,643 shares of West Pharmaceutical worth $1.67K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 4,290 West Pharmaceutical shares in Q2 2026, an estimated $1.31M.
  • West Pharmaceutical made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #380 holding.
  • Banque Cantonale Vaudoise first reported a position in West Pharmaceutical in Q4 2019 and has held it in 24 quarters since.
  • Banque Cantonale Vaudoise's West Pharmaceutical position peaked at $2.62M in Q3 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.